0.025 HKD
53.92 M HKD
380.20 M HKD
150.00 M
About MODERN CHINESE MEDICINE GRP CO LTD
Sector
CEO
Hong Li Zhang
Headquarters
Chengde
Website
Founded
1986
FIGI
BBG00YQ80WF2
Modern Chinese Medicine Group Co., Ltd. is an investment holding company, which engages in the distribution of medicines under the Yushi brand. It offers OTC and Prescribed Medicines. The firm’s products include circulation enhancement pills, vigour and vitality supplement pills, menstrual discomfort relief pills, cardiotonic enhancement capsules, kidney invigoration pills, heart wellness capsules, and liver detox tablets. The company was founded in 1986 and is headquartered in Chengde, China.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 1643 is 0.420 HKD — it has increased by 1.20% in the past 24 hours. Watch MODERN CHINESE MEDICINE GRP CO LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange MODERN CHINESE MEDICINE GRP CO LTD stocks are traded under the ticker 1643.
1643 stock has fallen by −5.62% compared to the previous week, the month change is a −10.64% fall, over the last year MODERN CHINESE MEDICINE GRP CO LTD has showed a 20.00% increase.
1643 reached its all-time high on Jan 15, 2021 with the price of 1.400 HKD, and its all-time low was 0.280 HKD and was reached on Sep 24, 2024. View more price dynamics on 1643 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
1643 stock is 0.00% volatile and has beta coefficient of 0.44. Track MODERN CHINESE MEDICINE GRP CO LTD stock price on the chart and check out the list of the most volatile stocks — is MODERN CHINESE MEDICINE GRP CO LTD there?
Today MODERN CHINESE MEDICINE GRP CO LTD has the market capitalization of 252.00 M, it has decreased by −5.62% over the last week.
Yes, you can track MODERN CHINESE MEDICINE GRP CO LTD financials in yearly and quarterly reports right on TradingView.
1643 net income for the last half-year is −7.42 M HKD, while the previous report showed 22.92 M HKD of net income which accounts for −132.40% change. Track more MODERN CHINESE MEDICINE GRP CO LTD financial stats to get the full picture.
MODERN CHINESE MEDICINE GRP CO LTD dividend yield was 0.00% in 2023, and payout ratio reached 0.00%. The year before the numbers were 0.00% and 0.00% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 27, 2024, the company has 191.00 employees. See our rating of the largest employees — is MODERN CHINESE MEDICINE GRP CO LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MODERN CHINESE MEDICINE GRP CO LTD EBITDA is 41.19 M HKD, and current EBITDA margin is 21.74%. See more stats in MODERN CHINESE MEDICINE GRP CO LTD financial statements.
Like other stocks, 1643 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MODERN CHINESE MEDICINE GRP CO LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MODERN CHINESE MEDICINE GRP CO LTD technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MODERN CHINESE MEDICINE GRP CO LTD stock shows the buy signal. See more of MODERN CHINESE MEDICINE GRP CO LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.